Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2023 and 2022, were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2023		2022		2023		2022
Net sales
Cardiovascular	$	306,084	$	278,949	$	905,335	$	832,555
Endoscopy		9,146		8,226		27,516		25,011
Total net sales		315,230		287,175		932,851		857,566
Income from operations
Cardiovascular		32,622		17,435		82,966		51,836
Endoscopy		2,515		1,222		7,366		5,310
Total income from operations		35,137		18,657		90,332		57,146
Total other expense — net		(4,915)		(1,055)		(9,710)		(4,672)
Income tax expense		4,388		2,330		13,840		11,359
Net income	$	25,834	$	15,272	$	66,782	$	41,115